BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25790467)

  • 1. Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.
    Luz D; Chen G; Maranhão AQ; Rocha LB; Sidhu S; Piazza RM
    PLoS One; 2015; 10(3):e0120481. PubMed ID: 25790467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of monoclonal antibodies against Shiga toxin 2 and their application for toxin detection in milk.
    He X; McMahon S; Skinner C; Merrill P; Scotcher MC; Stanker LH
    J Immunol Methods; 2013 Mar; 389(1-2):18-28. PubMed ID: 23279946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides derived from phage display libraries as potential neutralizers of Shiga toxin-induced cytotoxicity in vitro and in vivo.
    Bernedo-Navarro RA; Miyachiro MM; da Silva MJ; Reis CF; Conceição RA; Gatti MS; Yano T
    J Appl Microbiol; 2014 May; 116(5):1322-33. PubMed ID: 24447276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody.
    Luz D; Gómez FD; Ferreira RL; Melo BS; Guth BEC; Quintilio W; Moro AM; Presta A; Sacerdoti F; Ibarra C; Chen G; Sidhu SS; Amaral MM; Piazza RMF
    Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.
    Tremblay JM; Mukherjee J; Leysath CE; Debatis M; Ofori K; Baldwin K; Boucher C; Peters R; Beamer G; Sheoran A; Bedenice D; Tzipori S; Shoemaker CB
    Infect Immun; 2013 Dec; 81(12):4592-603. PubMed ID: 24082082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.
    Melli LJ; Zylberman V; Hiriart Y; Lauche CE; Baschkier A; Pardo R; Miliwebsky E; Chinen I; Rivas M; Goldbaum FA; Ugalde JE; Comerci DJ; Ciocchini AE
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31826960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
    Pellino CA; Karve SS; Pradhan S; Weiss AA
    J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of rabbit polyclonal sera against Shiga toxins Stx1 and Stx2 for detection of Shiga toxin-producing Escherichia coli.
    Mendes-Ledesma MR; Rocha LB; Bueris V; Krause G; Beutin L; Franzolin MR; Trabulsi LR; Elias WP; Piazza RM
    Microbiol Immunol; 2008 Oct; 52(10):484-91. PubMed ID: 18822082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of rabbit polyclonal sera against recombinant Shiga toxin and its subunits for detection of Stx-producing E. coli.
    Oloomi M; Bouzari S
    Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):41-6. PubMed ID: 21358014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2.
    Jeong KI; Chapman-Bonofiglio S; Singh P; Lee J; Tzipori S; Sheoran AS
    BMC Immunol; 2010 Mar; 11():16. PubMed ID: 20334660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.
    Basu D; Li XP; Kahn JN; May KL; Kahn PC; Tumer NE
    Infect Immun; 2016 Jan; 84(1):149-61. PubMed ID: 26483409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasensitive detection of Shiga toxin 2 and its variants in Shiga toxin-producing Escherichia coli strains by a time-resolved fluorescence immunoassay.
    Wen T; Huang C; Zhang Y; Zeng X; Liu W; Jiao Z; Guo X; Jiao Y
    Luminescence; 2018 May; 33(3):574-581. PubMed ID: 29350441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS).
    Mejías MP; Hiriart Y; Lauché C; Fernández-Brando RJ; Pardo R; Bruballa A; Ramos MV; Goldbaum FA; Palermo MS; Zylberman V
    Sci Rep; 2016 Apr; 6():24913. PubMed ID: 27118524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Immunoassay for Detecting All Subtypes of Shiga Toxins Produced by Shiga Toxin-Producing E. coli in Ground Beef.
    He X; Kong Q; Patfield S; Skinner C; Rasooly R
    PLoS One; 2016; 11(1):e0148092. PubMed ID: 26824247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities.
    Rocha LB; Luz DE; Moraes CT; Caravelli A; Fernandes I; Guth BE; Horton DS; Piazza RM
    Toxins (Basel); 2012 Sep; 4(9):729-47. PubMed ID: 23105978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
    Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
    Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a Shiga toxin 1-neutralizing recombinant Fab fragment isolated by phage display system.
    Inoue K; Itoh K; Nakao H; Takeda T; Suzuki T
    Tohoku J Exp Med; 2004 Aug; 203(4):295-303. PubMed ID: 15297734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects
    Luz D; Amaral MM; Sacerdoti F; Bernal AM; Quintilio W; Moro AM; Palermo MS; Ibarra C; Piazza RMF
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30513821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of B subunit-specific monoclonal antibody clones that strongly neutralize the toxicity of Shiga toxin 2.
    Arimitsu H; Sasaki K; Iba Y; Kurosawa Y; Shimizu T; Tsuji T
    Microbiol Immunol; 2015 Feb; 59(2):71-81. PubMed ID: 25521016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New high-affinity monoclonal antibodies against Shiga toxin 1 facilitate the detection of hybrid Stx1/Stx2 in vivo.
    Skinner C; Patfield S; Stanker LH; Fratamico P; He X
    PLoS One; 2014; 9(6):e99854. PubMed ID: 24914553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.